The clinical stage biopharma Anebulo Pharmaceuticals recently shared that it received positive FDA feedback after a Type B meeting in July, where the regulatory agency indicated a path to approval for ANEB-001, a competitive CB1 antagonist with a high affinity for the human CB1 receptor. Overstimulation of this receptor by cannabinoids such as THC causes […]

Glioblastoma (GBM) remains a difficult malignancy to treat, despite countless clinical trials that have introduced new therapies for patients with the disease, according to John de Groot, MD and Patrick Y. Wen, MD. However, targeting a novel mechanism of action could be the answer to improving the survival rates for these patients. The treatment modalities […]

A nonprofit health system in North Carolina has adopted a molecular test that analyzes a patient’s immune system to detect sepsis. FirstHealth of the Carolinas, a nonprofit health system licensed for four hospitals in North Carolina, will use Immunexpress’ SeptiCyte Rapid test to help differentiate sepsis-positive cases from patients with infection-negative systemic inflammation. The cartridge-based […]